Literature DB >> 12893428

Anticarcinogenic activity of natural sweeteners, cucurbitane glycosides, from Momordica grosvenori.

Midori Takasaki1, Takao Konoshima, Yuji Murata, Masaki Sugiura, Hoyoku Nishino, Harukuni Tokuda, Kazuhiro Matsumoto, Ryoji Kasai, Kazuo Yamasaki.   

Abstract

To search for cancer chemopreventive agents from natural resources, many phytochemicals and food additives have been screened. Consequently, two natural sweeteners, mogroside V and 11-oxo-mogroside V isolated from the fruits of Momordica grosvenori, exhibited strong inhibitory effect on the primary screening test indicated by the induction of Epstein-Barr virus early antigen (EBV-EA) by a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA). These sweet glycosides, having cucurbitane triterpenoid aglycon, exhibited the significant inhibitory effects on the two-stage carcinogenesis test of mouse skin tumors induced by peroxynitrite (ONOO-) as an initiator and TPA as a promoter. Further, 11-oxo-mogroside V also exhibited the remarkable inhibitory effect on two-stage carcinogenesis test of mouse skin tumor induced by 7,12-dimethylbenz[a]anthracene (DMBA) as an initiator and TPA as a promoter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893428     DOI: 10.1016/s0304-3835(03)00285-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1.

Authors:  Fangfang Song; Xiangyang Qi; Weijun Chen; Wenbo Jia; Ping Yao; Andreas K Nussler; Xiufa Sun; Liegang Liu
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

2.  Relative sweetness and sweetness quality of phyllodulcin [(3R)-8-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-3,4-dihydro-1H-isochromen-1-one].

Authors:  Min-Ji Kim; Sang-Ho Yoo; Yang Kim; Jae-Hee Hong
Journal:  Food Sci Biotechnol       Date:  2016-08-31       Impact factor: 2.391

Review 3.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance.

Authors:  Tanya Biswas; Upendra N Dwivedi
Journal:  Protoplasma       Date:  2019-07-11       Impact factor: 3.356

4.  Mogrol represents a novel leukemia therapeutic, via ERK and STAT3 inhibition.

Authors:  Can Liu; Yan Zeng; Long-Hai Dai; Tian-Yu Cai; Yue-Ming Zhu; De-Quan Dou; Lan-Qing Ma; Yuan-Xia Sun
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

5.  Studies on chemical fingerprints of Siraitia grosvenorii fruits (Luo Han Guo) by HPLC.

Authors:  Fenglai Lu; Dianpeng Li; Chuanming Fu; Jinlei Liu; Yonglin Huang; Yueyuan Chen; Yongxin Wen; Toshihiro Nohara
Journal:  J Nat Med       Date:  2011-06-30       Impact factor: 2.343

6.  An efficient approach to finding Siraitia grosvenorii triterpene biosynthetic genes by RNA-seq and digital gene expression analysis.

Authors:  Qi Tang; Xiaojun Ma; Changming Mo; Iain W Wilson; Cai Song; Huan Zhao; Yanfang Yang; Wei Fu; Deyou Qiu
Journal:  BMC Genomics       Date:  2011-07-05       Impact factor: 3.969

7.  Cloning and characterization of squalene synthase and cycloartenol synthase from Siraitia grosvenorii.

Authors:  Huan Zhao; Qi Tang; Changming Mo; Longhua Bai; Dongping Tu; Xiaojun Ma
Journal:  Acta Pharm Sin B       Date:  2016-08-23       Impact factor: 11.413

8.  Cucurbitane glycosides derived from mogroside IIE: structure-taste relationships, antioxidant activity, and acute toxicity.

Authors:  Lei Wang; Ziming Yang; Fenglai Lu; Jinglei Liu; Yunfei Song; Dianpeng Li
Journal:  Molecules       Date:  2014-08-20       Impact factor: 4.411

9.  Antioxidant Capacities of Hot Water Extracts and Endopolysaccharides of Selected Chinese Medicinal Fruits.

Authors:  Sang Chul Jeong; Ratna Tulasi; Sundar Rao Koyyalamudi
Journal:  Cancers (Basel)       Date:  2016-03-09       Impact factor: 6.639

10.  Mogroside V Protects against Hepatic Steatosis in Mice on a High-Fat Diet and LO2 Cells Treated with Free Fatty Acids via AMPK Activation.

Authors:  Linghuan Li; Wanfang Zheng; Can Wang; Jiameng Qi; Hanbing Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-30       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.